Prestige Consumer Healthcare develops, manufactures, markets, sells and distributes well-known, brand-name over-the-counter (OTC) health and personal care products, operating primarily in North America with additional international markets.

# Prestige Consumer Healthcare Inc.

## Company and identity
- Formed as a Delaware corporation in 1996.
- Formerly known as Prestige Brands Holdings, Inc. until August 17, 2018.

## Business focus
- Develops, manufactures, markets, sells, and distributes well-recognized, brand-name over-the-counter (OTC) health and personal care products.

## Markets and channels
- Serves mass merchandisers, drug/drug wholesale, food, dollar, convenience, club stores, and e-commerce channels.
- Geographic reach includes the United States, Canada, Australia, and certain other international markets.

## Competitive advantages and operating model
- Strong brand names, an established retail distribution network, and a low-cost operating model.
- Managed by an experienced leadership team.

## Growth strategy
- Pursues organic growth through brand extensions, new product lines, increased advertising and marketing support, and packaging and formulation improvements.
- Expands the portfolio through acquisitions of consumer health and personal care brands.
- Targets growth in the United States and international markets, including via acquisitions.

## Segments and structure
- Two reportable segments:
  - North American OTC Healthcare
  - International OTC Healthcare
- The company reports net revenues by segment to show each geographic/operational area’s contribution.

## Segment revenue mix (fiscal years ended March 31)
- North American OTC Healthcare:
  - 2026: 83.9%
  - 2025: 84.4%
  - 2024: 85.2%
- International OTC Healthcare:
  - 2026: 16.1%
  - 2025: 15.6%
  - 2024: 14.8%
- Total: 100.0% for each year

## Additional context
- The company discusses growth and risk factors in its Form 10-K; detailed risk disclosures are included in Part I, Item 1A.

Prestige Consumer Healthcare Inc. develops, manufactures, markets, and sells OTC health and personal care products across North America, Australia, and international markets, focusing on trusted brands and growth through acquisitions.

# Company Overview: Prestige Consumer Healthcare Inc.

## Business Focus
Prestige Consumer Healthcare Inc. develops, manufactures, markets, sells, and distributes over-the-counter (OTC) health and personal care products. The products are sold primarily through mass merchandisers, drugstores, grocery stores, dollar stores, convenience stores, club stores, and e-commerce platforms in North America (United States and Canada), Australia, and other international markets.

## Core Business Activities
- **Product Development:** Creating and innovating brand name OTC health and personal care products.
- **Manufacturing:** Outsourcing production to third-party manufacturers, with some products made in their own Lynchburg, Virginia facility. They also operate a manufacturing facility in Victoria, Australia.
- **Marketing & Sales:** Employing advertising campaigns, brand extensions, product line expansions, and marketing support to grow and maintain market share.
- **Distribution:** Broad retail distribution network, utilizing third-party logistics providers, with warehousing in Clayton, Indiana.
- **Acquisition Growth:** Growing through acquisitions of well-established brands from consumer and pharmaceutical companies, as well as private equity firms. Notable recent acquisition includes rights to Hydralyte in all jurisdictions except the U.S. in 2025 and assets from Akorn Operating Company LLC in 2022.
- **International Expansion:** International sales accounted for 15.6% of total revenues in 2025, with efforts to expand brands into new global markets.

## Key Products & Market Position
- **Major Brands:** These include BC, Goody's (analgesics), Boudreaux's Butt Paste (dermatologicals), Chloraseptic (sore throat relief), Clear Eyes (eye/ear care), Compound W (wart removal), Debrox (ear wax removal), DenTek (oral care), Dramamine (motion sickness), Fleet (gastrointestinal), Gaviscon (upset stomach), Luden’s (cough drops), Monistat (women’s health), Nix (lice/parasite treatments), Summer’s Eve (feminine hygiene), Fess (nasal saline), Hydralyte (oral rehydration), and others.
- **Market Leadership:** Numerous brands hold number one or strong market positions, with approximately 83% of total revenue generated by brands with a top market position in 2025.

## Financial Summary
- **Revenue (2025):** The company's net revenues are primarily generated from North American OTC products (about 84.4%) and international markets (about 15.6%).
- **Shareholders & Stock:** As of May 1, 2025, the company had approximately 49.4 million shares of common stock outstanding. Its market value was approximately $3.532 billion.
- **Revenue Concentration:** Top customers include Walmart (19%) and Amazon (14%). The company’s top ten customers, including these, account for a large and potentially growing share of total sales.
- **Employees:** The company employs approximately 600 employees globally—about 82% in the U.S., 16% in Australia and Asia, and 2% in Europe. 59% are salaried employees, and 41% are hourly workers. The workforce is 55% female and 45% male, with no unionized employees.
- **Share Repurchases:** The company has a share buyback program announced in May 2024, with up to $300 million of stock repurchased. During the first quarter of 2025, it bought back 137,724 shares at an average price of roughly $84.94 per share.

## Other Notable Data
- **Properties:** Headquarters in Tarrytown, NY; manufacturing in Lynchburg, VA; Australia facility; warehousing in Clayton, Indiana.
- **Regulatory & Industry:** The company operates under extensive U.S. federal and foreign regulations, including FDA, FTC, EPA, and foreign authorities. It owns trademarks and patents, though none are material individually.
- **Market Strategy:** Focus on diversified trusted brands, effective marketing, expanding distribution channels, international growth, and strategic acquisitions to sustain long-term growth.

---

*Note:* The summary strictly encapsulates provided data—no projections or hypotheticals are included.

Prestige Consumer Healthcare Inc. specializes in developing and distributing well-known brand name over-the-counter health and personal care products through a diverse retail network.

# Prestige Consumer Healthcare Inc.

## Business structure
Prestige Consumer Healthcare Inc. is a Delaware corporation founded in 1996. The company develops, manufactures, markets, sells, and distributes brand-name over-the-counter (OTC) health and personal care products across these retail channels:

- Mass merchandisers
- Drug stores
- Food stores
- Dollar stores
- Convenience stores
- Club stores
- E-commerce platforms

## Operations and segments
Operations are managed through two reportable segments:
1. North American OTC Healthcare  
2. International OTC Healthcare

## Products
The product portfolio spans multiple categories with well-known brands, including:
- Analgesics (BC, Goody's)
- Cough & cold (Chloraseptic)
- Women's health (Monistat)
- Gastrointestinal products (Dramamine, Gaviscon)
- Eye & ear care (Clear Eyes, Debrox)
- Dermatologicals (Compound W)
- Oral care (DenTek)

## Financial performance
- FY 2024 revenue: approximately $1.125 billion  
- FY 2024 net income: approximately $209.3 million  
- Market valuation: aggregate market value of voting and non-voting common equity held by non-affiliates was approximately $2.815 billion as of September 30, 2023

## Workforce
As of March 31, 2024, the company employed about 570 employees globally:
- 82% in the United States  
- 16% in Australia and Asia  
- 2% in Europe

## Customer base and manufacturing
Major customers:
- Walmart: ~19.7% of gross revenues in 2024  
- Amazon: ~10.9% of gross revenues in 2024

The company works with over 122 third-party manufacturers and generated approximately $1.125 billion in revenue across North American and international markets.

## Strategic focus
Key priorities include:
- Innovation: develop and launch new products to meet consumer needs  
- Acquisition growth: expand the brand portfolio through strategic acquisitions  
- Marketing investments: support brands via mass media, digital, and in-store channels  
- Operational efficiency: outsource manufacturing to third-party providers to maintain flexibility and lower cost structure

## Summary
Prestige Consumer Healthcare Inc. is a major participant in the OTC healthcare and personal care market, combining established brands, strategic acquisitions, and a focus on innovation and operational efficiency to drive growth and respond to consumer needs.

Prestige Consumer Healthcare Inc.

10-K / May 14, 2026

10-K / May 9, 2025

10-K / May 15, 2024

10-K / May 14, 2026

Prestige Consumer Healthcare Inc.

Company and identity

Business focus

Markets and channels

Competitive advantages and operating model

Growth strategy

Segments and structure

Segment revenue mix (fiscal years ended March 31)

Additional context